Tumor-induced death of immune cells: its mechanisms and consequences
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 12 (1) , 43-50
- https://doi.org/10.1006/scbi.2001.0402
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Fas/Fas Ligand Interaction in Human Colorectal Hepatic MetastasesThe American Journal of Pathology, 1999
- Tumor ImmunologyImmunity, 1998
- Depletion of the Natural Killer Cell Population in the Peritoneum by AK-5 Tumor Cells Overexpressing Fas-Ligand: A Mechanism of Immune EvasionCellular Immunology, 1998
- Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.Journal of Clinical Investigation, 1998
- Constitutive Expression of FasL in ThyrocytesScience, 1998
- Expression of Fas and Fas Ligand and Apoptosis in Tumor-Associated Lymphocytes and in Tumor Cells from Malignant Pleural EffusionsNatural Immunity, 1998
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996
- Metalloproteinase-mediated release of human Fas ligand.The Journal of Experimental Medicine, 1995
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- FAP-1: A Protein Tyrosine Phosphatase That Associates with FasScience, 1995